A Study For Pregabalin In Patients With Fibromyalgia

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

February 6, 2012

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions
Fibromyalgia
Interventions
DRUG

pregabalin

Pregabalin capsule, 300-450mg/day, twice daily

DRUG

placebo

Placebo, twice daily

Trial Locations (22)

100020

Beijing Chao-Yang Hospital, Capital Medical University, Beijing

100029

China-Japan Friendship Hospital/Rheumatology Department, Beijing

100032

Peking Union Medical College Hospital/Rheumatology Department, Beijing

100700

PLA. The Military General Hospital of Beijing, Beijing

150001

Rheumatology Department, The first Affiliated Hospital of Harbin Medical University, Harbin

150086

Rheumatology Department, The second Affiliated Hospital of Harbin Medical University, Harbin

200001

Rheumatology and Immunology Dept., Renji Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

200003

Rheumatology and Immunology Department, Shanghai Changzheng Hospital, Shanghai

200032

Zhongshan Hospital Fudan University, Rheumatology Department, Shanghai

230001

Anhui Province Hospital, Hefei

233000

Department of Rheumatism And Immunity, The First Affiliated Hospital of Bengbu Medical College, Bengbu

325000

The First Affiliated Hospital of Wenzhou Medical University/Neurology Department, Wenzhou

330006

The Second Affiliated Hospital to Nanchang University, Nanchang

400038

Southwest Hospital of the Third Military Medical University,PLA, Chongqing

410008

Xiangya Hospital of Centre-south University, Changsha, Kaifu District

510010

Department of Neurology,General Hospital of Guangzhou Military Command of PLA, Guangzhou

510080

Guangdong General Hospital, Guangzhou

510120

Department of Neurology,The First Affiliated Hospital Of Guangzhou Medical University, Guangzhou

510630

The Third Affiliated Hospital Of Sun Yat-sen University, Guangzhou

610041

Si Chuan Huaxi Hospital/Rheumatology Department, Chengdu

650032

The First Affiliated Hospital of Kunming Medical University/ Rheumatology and Immunology Department, Kunming

710032

Xijing Hospital, The Fourth Military Medical University, Xi’an

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT01387607 - A Study For Pregabalin In Patients With Fibromyalgia | Biotech Hunter | Biotech Hunter